CONMED Corporation, a prominent medical technology company, develops, manufactures, and sells a diverse range of surgical devices and related equipment for surgical procedures across the globe. The company recorded an operating income of $200,326,000.00 reflecting its earnings from core operations. It specializes in orthopedic surgery products, which include the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, all designed to provide unique clinical solutions for orthopedic surgeons managing soft tissue injuries. The gross profit ratio is 0.56 reflecting the efficiency of the company’s production and sales operations. Additionally, the company supports products that facilitate minimally invasive sports medicine surgeries, marketing these orthopedic innovations under well-recognized brands including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, the company reported an income before tax of $163,029,000.00 showcasing its pre-tax profitability, while the income before tax ratio is 0.12 which reflects the pre-tax margin. It also incurs an interest expense of $37,297,000.00 reflecting its debt servicing obligations. In addition to orthopedic products, CONMED provides general surgery products such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical devices, alongside endoscopic technologies for gastroenterology, cardiac monitoring including ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its offerings directly to hospitals, surgery centers, and other healthcare institutions, along with collaborations through medical specialty distributors. Incorporated in 1970, CONMED Corporation is headquartered in Largo, Florida. In the financial sphere, the stock is reasonably priced at $57.69 appealing to a broad range of investors. With a mid-range market capitalization of $1,755,839,325.00 the company is recognized as a steady performer in its sector. It belongs to the Healthcare sector, driving innovation and growth within the industry. Notably, the stock has a low average trading volume of 490,960.00 indicating lower market activity, and CONMED stands out as a key player in the Medical - Devices industry, contributing significantly to the overall market landscape. The blend of its innovative products and strategic market positioning underscores the company’s role as a vital contributor to advancing medical technology.